Interim Condensed Consolidated Statements Of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Dec. 28, 2018	Dec. 29, 2017
Revenue:
Licensing	$ 260,279	$ 270,172
Products	42,097	29,355
Total revenue	302,376	299,527
Cost of revenue:
Cost of licensing	11,397	9,259
Cost of products and services	27,232	21,634
Total cost of revenue	38,629	30,893
Gross margin	263,747	268,634
Operating expenses:
Research and development	58,647	56,444
Sales and marketing	85,602	70,149
General and administrative	50,813	48,285
Restructuring charges/(credits)	14	(197)
Total operating expenses	195,076	174,681
Operating income	68,671	93,953
Other income/expense:
Interest income	5,185	3,781
Interest expense	(45)	(35)
Other income/(expense), net	443	(1,152)
Total other income	5,583	2,594
Income before income taxes	74,254	96,547
Provision for income tax (expense) benefit	24,104	(149,705)
Net income (loss) including controlling interest	98,358	(53,158)
Less: net (income) attributable to controlling interest	(139)	(144)
Net income (loss) attributable to Dolby Laboratories, Inc.	$ 98,219	$ (53,302)
Net income (loss) per share:
Basic (in usd per share)	$ 0.96	$ (0.52)
Diluted (in usd per share)	$ 0.93	$ (0.52)
Weighted-average shares outstanding:
Basic (in shares)	102,677	102,552
Diluted (in shares)	106,130	102,552
Related party rent expense:
Included in operating expenses	$ 880	$ 784
Included in net income attributable to controlling interest	$ 176	$ 177
Common stock, dividends declared (in dollars per share)	$ 0.19	$ 0.16
Common Stock, Dividends, Per Share, Cash Paid	$ 0.19	$ 0.16